106 related articles for article (PubMed ID: 8453577)
1. Evidence of tumor heterogeneity in cervical cancers and lymph node metastases as determined by flow cytometry.
Nguyen HN; Sevin BU; Averette HE; Ramos R; Ganjei P; Perras J
Cancer; 1993 Apr; 71(8):2543-50. PubMed ID: 8453577
[TBL] [Abstract][Full Text] [Related]
2. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
Zanetta GM; Katzmann JA; Keeney GL; Kinney WK; Cha SS; Podratz KC
Gynecol Oncol; 1992 Jul; 46(1):13-9. PubMed ID: 1634134
[TBL] [Abstract][Full Text] [Related]
3. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix.
Kenter GG; Cornelisse CJ; Aartsen EJ; Mooy W; Hermans J; Heintz AP; Fleuren GJ
Gynecol Oncol; 1990 Nov; 39(2):181-5. PubMed ID: 2227593
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
6. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.
Kristensen GB; Kaern J; Abeler VM; Hagmar B; Tropé CG; Pettersen EO
Gynecol Oncol; 1995 Apr; 57(1):79-85. PubMed ID: 7705705
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma.
Piver MS; Chung WS
Obstet Gynecol; 1975 Nov; 46(5):507-10. PubMed ID: 1196552
[TBL] [Abstract][Full Text] [Related]
8. DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b.
Horn LC; Raptis G; Nenning H
Anal Quant Cytol Histol; 2002 Feb; 24(1):23-9. PubMed ID: 11865946
[TBL] [Abstract][Full Text] [Related]
9. The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinoma.
Lai CH; Hsueh S; Huang MY; Chang MF; Soong YK
Cancer; 1993 Dec; 72(12):3655-62. PubMed ID: 8252482
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
11. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
12. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
[TBL] [Abstract][Full Text] [Related]
14. [Lymph node metastasis as a prognostic factor in cervical carcinoma].
Kobierski J; Emerich J; Królikowska B; Majdak E
Ginekol Pol; 2002 Nov; 73(11):925-9. PubMed ID: 12722375
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral cavity and oropharynx.
Syms CA; Eibling DE; McCoy JP; Barnes L; Emanuel B; Fowler C; Wagner R; Johnson JT
Laryngoscope; 1995 Feb; 105(2):149-55. PubMed ID: 8544594
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
18. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
[TBL] [Abstract][Full Text] [Related]
19. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
20. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
